Loading records…

Public procurement

NP47825 Multiple Sclerosis Medicines

See the published facts, notice history, awards and supplier links in one place. Open the original Find a Tender notice for the full record.

View record reference

ocds-h6vhtk-04ce06

Published facts

What the notice says

Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Published status: complete
Latest release reference: 018635-2025
CPV codes: Common Procurement Vocabulary (CPV) codes: 33600000
Published tags: award, contract
Latest record Bidwake loaded from this source: 27 Aug 2026

Supply of multiple sclerosis medicines to NHS Scotland.

Open the official Find a Tender notice

Observed notice trail

How the published record developed

Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.

Award notice observed
2 May 2025
Latest variant observed by Bidwake on 16 Jul 2026.
Open this official Find a Tender notice
Record references
Release reference
018635-2025
Published tags
award, contract

Awards and suppliers

Published award and contract facts

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Supplier: Biogen Idec Ltd
End date in notice
Date not published
Value shown in notice
£47,968,904Value from the linked contract
Official source
Open the official Find a Tender notice for Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
- This figure comes from the linked contract record. Overall totals continue to use the separately published award value.
View record references
Source
Find a Tender
Award or lot reference
018635-2025-1
Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

How to read the dates and links

End dates, recurrence wording and links are shown as they appear in public notices. They do not create a new opportunity. If no later linked record appears here, that means Bidwake did not find one in the records it has loaded; it does not prove that none exists.

NP47825 Multiple Sclerosis Medicines

What the notice says

How the published record developed

2 May 2025

Published award and contract facts

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

How to read the dates and links

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules

Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules

Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules

What the notice says

How the published record developed

2 May 2025

Published award and contract facts

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Published terms and linked processes

How to read the dates and links

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules

Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules

Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules